drugset / Trial / NCT02404103
Flunisolide HFA in Children With Small Airway Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to see how two doses of Flunisolide HFA (an FDA approved inhaled medication to treat asthma) affect the small airways in children with asthma.
Timeline
- Start
- 2015-03
- Primary completion
- 2017-05
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Flunisolide | Small molecule | 80 ug | Inhaled |
| Comparator | Flunisolide | Small molecule | 160 ug | Inhaled |